Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.
- Published In:
- Cancer immunology, immunotherapy : CII, 63(6), 601-13 (2014)
- Authors:
- Camilio, Ketil André, Berge, Gerd(4), Ravuri, Chandra Sekhar, Rekdal, Oystein, Sveinbjørnsson, Baldur
- Database ID:
- RPEP-02345
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02345APA
Camilio, Ketil André; Berge, Gerd; Ravuri, Chandra Sekhar; Rekdal, Oystein; Sveinbjørnsson, Baldur. (2014). Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.. Cancer immunology, immunotherapy : CII, 63(6), 601-13. https://doi.org/10.1007/s00262-014-1540-0
MLA
Camilio, Ketil André, et al. "Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.." Cancer immunology, 2014. https://doi.org/10.1007/s00262-014-1540-0
RethinkPeptides
RethinkPeptides Research Database. "Complete regression and systemic protective immune responses..." RPEP-02345. Retrieved from https://rethinkpeptides.com/research/camilio-2014-complete-regression-and-systemic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.